Fintel on MSN

Alpha Tau Medical (DRTS) price target increased by 15.15% to 9.69

The average one-year price target for Alpha Tau Medical (NasdaqCM:DRTS) has been revised to $9.69 / share. This is an ...

Alpha Tau Medical: 2026 Is The Breakthrough Year

Alpha DaRT alpha-particle therapy, key 2026 trial catalysts, cash/dilution risks, and M&A takeover potential. See more.

Defiance S&P 500 Target Income ETF declares monthly distribution of $0.2638

Payable Apr 02; for shareholders of record Apr 01; ex-div Apr 01. More on Defiance S&P 500 Target Income ETF SPYT: Covered Call Strategy As An Alternative To Fixed Income Seeking Alpha’s Quant Rating ...

Target-date funds promise simplicity but may leave retirement risks unchecked

Target-date mutual funds have become a cornerstone of retirement saving, offering a hands-off approach that automatically shifts investments from stocks to safer assets over time. But financial ...
Nasdaq

Alpha Bank S.A. - Depositary Receipt (ALBKY) Price Target Increased by 81.04% to 1.66

The average one-year price target for Alpha Bank S.A. - Depositary Receipt (OTCPK:ALBKY) has been revised to $1.66 / share. This is an increase of 81.04% from the prior estimate of $0.92 dated ...

Alpha Tau Medical Conference: Japan Approval, Rolling FDA PMA, and Big 2026 Data Readouts Teased

Alpha Tau Medical (NASDAQ:DRTS) provided investors with a series of clinical, regulatory and financial updates, highlighting what company leadership described as “real and meaningful activity” over ...